The benefits of ω-3 supplementation depend on adiponectin basal level and adiponectin increase after the supplementation: A randomized clinical trial.

[1]  Chih-Yu Chen,et al.  Omega-3 Fatty Acid Intervention Suppresses Lipopolysaccharide-Induced Inflammation and Weight Loss in Mice , 2015, Marine drugs.

[2]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[3]  J. Buckley,et al.  Relationship between Erythrocyte Omega-3 Content and Obesity Is Gender Dependent , 2014, Nutrients.

[4]  B. Stratmann,et al.  Effects of n-3 Polyunsaturated Fatty Acids (PUFAs) on Circulating Adiponectin and Leptin in Subjects with Type 2 Diabetes Mellitus , 2013, Hormone and Metabolic Research.

[5]  T. Kadowaki,et al.  Adiponectin receptors: a review of their structure, function and how they work. , 2014, Best practice & research. Clinical endocrinology & metabolism.

[6]  D. Mozaffarian,et al.  Effect of fish oil on circulating adiponectin: a systematic review and meta-analysis of randomized controlled trials. , 2013, The Journal of clinical endocrinology and metabolism.

[7]  J. Nessler,et al.  Omega-3 Polyunsaturated Fatty Acids Increase Plasma Adiponectin to Leptin Ratio in Stable Coronary Artery Disease , 2013, Cardiovascular Drugs and Therapy.

[8]  M. Rafraf,et al.  Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. , 2012, Asia Pacific journal of clinical nutrition.

[9]  E. López-Huertas.  The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials , 2012, British Journal of Nutrition.

[10]  T. E. S. Faulin,et al.  Development of immunoassays for anti-electronegative LDL autoantibodies and immune complexes. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[11]  A. Alsaleh,et al.  Effect of interaction between PPARG, PPARA and ADIPOQ gene variants and dietary fatty acids on plasma lipid profile and adiponectin concentration in a large intervention study , 2011, Proceedings of the Nutrition Society.

[12]  K. Lam,et al.  Cross‐talk between adipose tissue and vasculature: role of adiponectin , 2011, Acta physiologica.

[13]  A. Alsaleh,et al.  Single nucleotide polymorphisms at the ADIPOQ gene locus interact with age and dietary intake of fat to determine serum adiponectin in subjects at risk of the metabolic syndrome. , 2011, American Journal of Clinical Nutrition.

[14]  Faha,et al.  Aha Guideline Effectiveness-based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update a Guideline from the American Heart Association Executive Writing Committee Expert Panel Members Cvd Risk Assessment Table 1. Class Iii Interventions (not Useful/effective and May Be Harmfu , 2022 .

[15]  L. Defina,et al.  Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. , 2011, The American journal of clinical nutrition.

[16]  M. Quon,et al.  Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. , 2009, Atherosclerosis.

[17]  A. M. Lottenberg.  Importância da gordura alimentar na prevenção e no controle de distúrbios metabólicos e da doença cardiovascular , 2009 .

[18]  T. E. S. Faulin,et al.  Validation of a novel ELISA for measurement of electronegative low-density lipoprotein. , 2008 .

[19]  E. Komives,et al.  The IκBα/NF‐κB complex has two hot spots, one at either end of the interface , 2008, Protein science : a publication of the Protein Society.

[20]  A. Leite-Moreira,et al.  Cardiovascular actions of adiponectin: pathophysiologic implications. , 2008, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[21]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[22]  H. Kondo,et al.  Dietary fish oil upregulates intestinal lipid metabolism and reduces body weight gain in C57BL/6J mice. , 2007, The Journal of nutrition.

[23]  K. Clément,et al.  Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. , 2007, The American journal of clinical nutrition.

[24]  Y. Kamei,et al.  Increased Adiponectin Secretion by Highly Purified Eicosapentaenoic Acid in Rodent Models of Obesity and Human Obese Subjects , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[25]  Christopher J. Williams,et al.  Heritability of plasma adiponectin levels and body mass index in twins. , 2007, The Journal of clinical endocrinology and metabolism.

[26]  Maria das Graças Tavares do Carmo,et al.  Adipocitocinas: uma nova visão do tecido adiposo , 2007 .

[27]  L. Oyama,et al.  Effects of different fatty acids and dietary lipids on adiponectin gene expression in 3T3-L1 cells and C57BL/6J mice adipose tissue , 2007, Pflügers Archiv - European Journal of Physiology.

[28]  M. Gillum,et al.  Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. , 2006, Diabetes.

[29]  P. Flachs,et al.  Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce β-oxidation in white fat , 2005, Diabetologia.

[30]  G. Slama,et al.  Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[31]  Ken Williams,et al.  Identification of individuals with insulin resistance using routine clinical measurements. , 2005, Diabetes.

[32]  A. Simopoulos.  Genetic variation: nutritional implications. , 2004, World review of nutrition and dietetics.

[33]  P. Ferré,et al.  The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. , 2004, Diabetes.

[34]  N. Espat,et al.  NF-κB inhibition by ω-3 fatty acids modulates LPS-stimulated macrophage TNF-α transcription , 2003 .

[35]  S. Uchida,et al.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.

[36]  L. Storlien,et al.  Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. , 2002, American journal of physiology. Endocrinology and metabolism.

[37]  X. Deng,et al.  Regulation of the rat SREBP-1c promoter in primary rat hepatocytes. , 2002, Biochemical and biophysical research communications.

[38]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[39]  T. Osborne,et al.  Polyunsaturated Fatty Acids Decrease Expression of Promoters with Sterol Regulatory Elements by Decreasing Levels of Mature Sterol Regulatory Element-binding Protein* , 1998, The Journal of Biological Chemistry.

[40]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[41]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[42]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.